PROFILE COMMISSION |
|
Shilov E.M., Shilova M.M., Rumyantseva E.I., Batyushin M.M., Bevzenko A.Yu., Belskikh A.N., Veselkova N.V., Yesayan A.M., Ivliev S.V., Kotenko O.N., Petrova N.Yu., Statsenko M.E., Stolyar A.G.
Nephrology Service of the Russian Federation 2024: Part I. Renal Replacement Therapy
|
6-17 |
ORIGINAL PAPERS |
|
Perepelitsa S.A.
Gender differences in kidney function in COVID-19
|
18-21 |
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Yusupov F.A., Yusupova T.F., Yusupova Z.F., Duysheeva G.K., Khakimov Sh.Sh., Abdurakhmanov I.U., Solizhonov Zh.I., Ymankulov D.S., Khabibullaev K.K.
Right ventricle, pulmonary pressure and their relationship with renal function in patients with overweight and obesity
|
22-28 |
Mikhailova L.V., Perepelitsa S.A., Struchkov S.T., Orlova Yu.A., Akchurina K.N.
Acute kidney injury in patients with COVID-19: severity of inflammatory response and risk of chronic kidney disease development
|
29-32 |
Abdurakhimov A.Kh.
Analysis of demographic, clinical and laboratory parameters in patients with COVID-19 with acute kidney injury
|
33-36 |
NEPHROUROLOGY |
|
Andreev S.S., Trushkin R.N., Isaev T.K., Artyukhina L.Yu., Frolova N.F., Ilyukhina N.N., Narusova P.O., Abdullaev Sh.P., Dushkin A.D., Lysenko M.A., Zhuravleva M.V.
Predictors of fatal outcome in patients hospitalized for renal pyelonephritis
|
37-46 |
KIDNEY DISEASES |
|
Kulchavenya E.V., Kholtobin D.P., Shevchenko S.Yu.
Chronic pyelonephritis as a mimics of kidney tuberculosis
|
47-52 |
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Yusupov F.A., Yusupova T.F., Yusupova Z.F., Duysheeva G.K., Khakimov Sh.Sh., Solizhonov Zh.I., Ymankulov D.S.
Clinical cases of acute kidney injury under conditions of exposure to short-term abnormal heat waves
|
53-60 |
Zubeev P.S., Kharlamova O.V., Motylev I.M., Zubeeva G.N., Suslova O.A., Shilov E.M.
Acute kidney damage due to statin taken: case description and literature review
|
61-66 |
LITERATURE REVIEWS |
|
Vershinina A.Ch., Vershinin P.Yu.
Thrombotic microangiopathies: differential diagnosis and choice of treatment strategy
|
67-75 |
Levchenkova O.S., Novikov V.E., Vorobyeva V.V., Kozlov S.N.
Hif-prolylhydroxylase inhibitors: the future for anemia treatment in patients with chronic kidney disease
|
76-85 |
Lelyavina T.A., Galagudza M.M., Sonin D.L., Popov S.V., Guseinov R.G., Beshtoev A.Kh., Malyshev E.A.
Prevalence and pathogenesis of kidney damage in non-alcoholic fatty liver disease – the possibilities of early diagnosis using fluorescence organoscopy
|
86-94 |